We would love to hear your thoughts about our site and services, please take our survey here.
Good luck BB hopefully in a few months time any purchase under 25p will be looked back on as being a shrewd investment. I'm still of the opinion this technology is not going to be left to collect dust, how generous the next backer will be is key. Plenty of wealthy individuals who could bank roll this it's just on what terms to appease existing shareholders. At this low level the 25p warrants are looking like an amicable solution although when you've paid around 100p for shares as has been the case for many supporting avo along its journey it's a long way down.
Well to lower my average I purchased just over 80k shares middle of this year for around 23p so looking at these director purchases with a bit of envy as at this price I would have had a much better average. Unfortunately can't put anymore funds here but pleased & somewhat relieved to see these purchases be good to see NS join in. Having said that maybe it would be preferable to participate in a fund raise at 25p then at least avo get the cash.
It might not improve the sp but this is a strong sign everything is continuing as expected towards first patient treatment and accreditation.
Another why not has appeared on the advfn bb with a story about ari6000. It's completely new news to me might be accurate and doesn't look good if true. But you have to ask why bring it up at this late stage to undermine the story. There are people desperately trying to create negativity and not just for fun so I'll take it as a positive that they are making such a big effort which can only be to protect shorters or to accumulate cheap shares.
It's a bit of a strange one, you don't normally get advance warning of imminent great news and miss the boat. But here we are expecting a major announcement and told it will be early January. The sp is definitely not reacting to what we think will be announced. Imagine where the sp would be if they just issued the actual rns instead of it will be early January.
I'm holding and hoping somehow the market has got this wrong. I've been on the wrong side before maybe this one will work out haven't long to find out GLA especially those who have been here a few years and held all through the covid test saga this really will be redemption!
It's only a token gesture but an important one at that. I think it tells the market the path to first patient treatment & accreditation continues in spite of what the battered sp might lead you to believe
It seems the world of science are more impressed with this achievement than the investment community. It's a world first and a major technological milestone that should advance proton therapy treatment. If they can harness the commercial opportunity and it starts to bear fruit then no doubt the investment world will take note as this has the potential to be huge in terms of value. What we need is another £20m or so of funds, around 200m shares including warrants and a clearly communicated plan through to patient treatment and full accreditation. This should include details of expected orders & associated short term revenues via deposits or the unique finance arrangement they have set up, arrangements for manufacturing and a timescale for Harley Street to be up & running. I doubt we'll get all this information but any signs or news of interim progress on any of these points should hopefully result in investor interest. The funding issue is a big one with tons of 25p warrants already issued and the amount needed to get to Q4 2023 and what will be attached to these funds. The market needs to know finances are in place and the number of shares required to achieve this as we're looking at possibly 7 or 800million or more by the end of next year. A view of the size of a growing order book will allow the market to attribute a future value to the shares until then the market can hammer the shares as we are now witnessing as doubt exists in the ability to fund and execute this final phase of the project. Remove the doubt and the sp will be fine.
Take your point on ramping but hardly seems possible at the moment. Hoping the truly good companies come through this period with better outcomes next year.
For some perspective regarding dilution take a look at ygen which highlights how difficult it is to raise funds in this market. Makes the fund raising here look not too bad and hopefully avo can raise more without giving away too much.
How strange I didn't even notice perhaps because I'm also invested in avacta and funnily enough have been in avo since around 2014. You're not in cpx as well by any chance.
All 3 appear to be on the cusp of greatness after years in the doldrums but you wouldn't think so by the current sp. I've maintained a lth approach and accumulated over the years patience is beginning to wear thin but maybe next year who knows. Unbelievable what is happening here when you see what they have built and all the science behind it if it truly works as explained with the potential of single flash treatments it's futuristic star trek stuff. 2 to £300m wouldn't be unrealistic a valuation in its current state by comparison to some of the rubbish on aim but this current market is brutal across the board with most companies suffering. If this really does what they say it will shine through and not fade away like some of the no hopers are doing at present.
Good luck max you'd have to think that average would work out well. Mine is a bit more but I'm still hopeful whatever the outcome here I'll see some sort of return. The recent large institutional investments would lead you to believe that some sort of due diligence was carried out to have highlighted a positive near term outcome. A reassuring update wouldn't be amiss but I believe without news of a good funding deal, orders and accreditation progress the market is not going to buy this. Maybe a takeover deal will be the only option, something I had thought was inevitable but swayed in my opinion with the news of 230MeV & confirmation of their plans to achieve commercialisation. They really need to be manufacturing the Harley St machine so it can be installed and made ready as soon as possible following completion of accreditation. More funding is required either through a takeover or equity raise and further dilution but the 25p warrants are becoming a concern. Fingers crossed time now!
Well I was certainly expecting the existing letters of intent and additional new contracts to be formally signed as firm orders before year end. Was expecting the run up to accreditation to be dominated with good news and feel like a victory parade but this is not beginning to look like Christmas...where is Santa!
This is one seriously undervalued company that is going to have to prove itself with the numbers around February in the half year report. Only slight concern is that they have already said this years numbers will be H2 loaded so hopefully some carefully chosen words are used to clarify the situation. They'll be well into Q3 by then so should have a good view on orders right up to the end of the year
It does feel that way but as I've said the long term major shareholders including Odey Asset Management will not prevent funds being made available to complete this last phase taking it to human trials. If you can get your average down to anywhere near 25p you'll probably be ok. I'll need a bit more than that so hoping for a bit of commercial progress a well
Some relatable sensible comments StarBright. This is looking extremely positive & it's great to have dates when news will be provided and then we will see the market reaction. At least it will put an end to much of the unnecessary debate here but as you say it may not be that simple as if it ever is but for many good reasons let's hope this advances how we hope & expect!
Best just to wait for updates, 230MeV is still a great achievement. The accreditation and patient treatment stages are crucial steps in the commercialisation process. Unfortunately these are a few months away and as we well know funding is required. The markets are dire and things appear bleak at present but this can quickly change. You may be correct and the sp drops further but this is backed by some loyal long term investors who I believe will ensure it succeeds and hopefully the sp will then follow.
Have to agree with you there Cornish however if sales are reported inline with brokers forecasts for half yearly & end of year reports then these announcements must be resulting in orders. No doubt we'd probably maintain a more consistent sp with regular news of deals with values attached but achieving end of year targets should also get the sp to where we think it should be. Markets are on a downwards spiral at the moment we'll just have to wait and see if cpx can break out of it with good results if not what else are you supposed to invest in all the pipedreams are going bust this is a real money making business so I'm staying put.